Oct 2026· Frontiers in Immunology· Vol 17· 0 citations· 201 references
Medicine
TL;DR
This review summarizes current advances in the understanding of neutrophil-mediated regulation of bone metabolism, focusing on their dual roles in osteogenesis and osteoclastogenesis.
Abstract
Bone homeostasis is maintained through a dynamic balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. With the rapid development of osteoimmunology, increasing attention has been directed toward the role of immune cells in the regulation of bone metabolism. Neutrophils, as the most abundant innate immune cells in the bone marrow, are now recognized not only as key effectors of inflammation but also as important regulators of bone microenvironment homeostasis and bone remodeling. This review summarizes current advances in the understanding of neutrophil-mediated regulation of bone metabolism, focusing on their dual roles in osteogenesis and osteoclastogenesis. During the early stages of bone repair, neutrophils may facilitate bone regeneration by clearing necrotic debris, promoting angiogenesis, and modulating mesenchymal stem cells (MSCs) function. However, in pathological settings such as persistent inflammation, metabolic dysfunction, and aging, neutrophil dysregulation can suppress osteogenesis and enhance osteoclastogenesis through the release of inflammatory mediators, reactive oxygen species, and neutrophil extracellular traps (NETs), ultimately contributing to bone metabolic imbalance. Notably, NETs exhibit context-dependent effects in bone remodeling and may either support repair or aggravate bone destruction under different pathological conditions. Overall, neutrophils function as critical intermediates linking immune responses with bone remodeling. Their diverse effects on bone metabolism are largely determined by their activation status and the surrounding microenvironment. Elucidating the mechanisms underlying neutrophil-mediated regulation of bone metabolism may offer new insights and potential therapeutic targets for osteoporosis, inflammatory bone destruction, and impaired bone healing.
Osteoporosis has long been understood, and treated, as an imbalance between osteoblastic bone formation and osteoclastic resorption. Yet many patients continue to lose bone, pointing to upstream regulators of the remodeling unit that remain poorly defined. Macrophages are developmentally continuous with osteoclasts and...
Lian Weng, Qian-Li Yuan, T. Mo et al.· Frontiers in Immunology· 0 citations
This review summarizes the current evidence that H₂S participates in skeletal remodeling through coordinated regulation of osteoblast-lineage cells, osteoclasts, macrophage-mediated immune responses, and metabolic stress adaptation.
Bone homeostasis is a dynamic process governed by the balanced activity of osteoblasts and osteoclasts, tightly regulated through complex signaling networks. Emerging evidence highlights sphingolipid metabolism as a critical modulator of skeletal integrity, influencing bone remodeling in both health and disease. Each i...
Jett B. Murray, Peter Kim, P. Lehmann et al.· Lipidology· 0 citations
Bone homeostasis depends on coordinated activity among bone marrow mesenchymal stem cells, osteoblasts, osteocytes, and osteoclasts. Disruption of this cellular network contributes to osteoporosis, impaired fracture repair, and other skeletal disorders, while redox stress and regulated cell-death programs increasingly...
Jiang-Ying Zhang, Xi-Ping Dou, Hao-Chuan You et al.· Biomolecules· 0 citations
Osteoporosis (OP) is a multifactorial skeletal disorder characterized by progressive bone loss, microarchitectural deterioration and an increased risk of fragility fractures resulting from disrupted bone remodeling. Integrin αVβ3 functions as an important regulator of bone homeostasis by coordinating bone cell-extracel...
Chang-Shun Chen, Xing-Xi Hu, Si-Xing Wei et al.· Molecular Medicine Reports· 0 citations